by Brian O’Shea at Investigate Everything with Brian O’Shea
BACKGROUND:
NEW YORK – [Jan. 25, 2023] “Project Veritas released a new video today exposing a Pfizer executive, Jordon Trishton Walker, who claims that his company is exploring a way to ‘mutate’ COVID via ‘Directed Evolution’ to preempt the development of future vaccines.” -Project Veritas
Essentially Dr. Walker said a lot that I think we all suspected but now we can be pretty sure we knew. So is he an actual Pfizer Senior Executive? So far it looks like he’s the real deal, though he may be on loan to Pfizer from the Boston Consulting Group (“BCG”). However, like with any case, I put my excitement aside and started to do what I do as a standard practice in my work as a Private Intelligence and Security Consultant: Human Capital Due Diligence (aka Due Diligence on Human Sources).
I don’t want to waste time with lots of narrative, so I will just share what I’ve found since 8pm.
(Disclaimer: I love and respect Project Veritas and their work is excellent. This in no way indicates I doubt their due diligence practices. I just like to check things out for myself when I cannot see sources or citations which were not available when the video first came out. All the same, they did, in fact do excellent due diligence which became available throughout tonight during a 3 hour Twitter Spaces conference hosted by Project Veritas.).
(Disclaimer 2: All information found is publicly available. It may be hard to find soon, so I have indexed every URL cited here on WayBack Machine and have downloaded PDF – Print versions of every page mentioned here).
(I also wanted to give a gigantic THANK YOU to Project Veritas! They are all heroes, and we should all support their work in anyway we can!)
The key takeaways that I want to highlight, based on the results below are somewhat chilling in the context of the “pandemic,” Covid-19, Pfizer’s and the FDA’s cozy relationship with China, and the timing of Dr Walker’s experience with the pandemic and all of its outcomes:…
Continue Reading